Culture Media Microdroplet Geometry With Different Oil Overlay and Its Effect on Embryonic Development.

July 22, 2020 updated by: Ganin Fertility Center

The Effect of Culture Media Microdroplet Geometry and Different Oil Overlay on Pre Implantation Embryonic Development in Dry Incubators: Prospective Randomized Study.

A prospective randomized study included 1695 MII sibling oocytes collected from 100 patients undergoing ICSI.

Study Overview

Detailed Description

Purpose:

to determine the effect of culture media microdroplet geometry of different culture dishes and oil overlay on the pre implantation embryo development in dry incubators

Method:

We used sibling oocytes splits between two different dishes : GPS (life global, USA) and SPL (life science, Korea) with two different oils : light mineral oil (LM)(Irvine, USA) and paraffin oil (PO)(Vitro life, Sweden). All embryos cultured in dry incubators at the same conditions.

statistical analysis done using SPSS version 23

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11728
        • Ganin Fertility Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 37 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female age is ≤ 37 years old with ≥ 8 MII oocytes
  • Males with normal semen parameters (WHO 2010).
  • We conducted three experiments all with Siblings oocytes splits and all embryos

Exclusion Criteria:

  • Oocyte or sperm donation.
  • Sever male factor.
  • Any contradictions to undergoing in vitro fertilization or goandotropin stimulation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: GPS / LM versus SPL/LM
to determine the effect of micro droplet geometry in 3D dishes (GPS) or 2D dishes (SPL) in combination with light mineral oil (LM).
Media microdroplet geometry (3D dishes) in combination with light mineral oil overlay
Media microdroplet geometry (2D dishes) in combination with light mineral oil overlay
Other: GPS/PO versus SPL/PO
to determine the effect of micro droplet geometry in 3D dishes (GPS) or 2D dishes (SPL) in combination with paraffin oil (PO).
Media microdroplet geometry (3D dishes) in combination with Paraffin oil overlay
Media microdroplet geometry (2D dishes) in combination with paraffin oil overlay
Other: GPS/PO versus GPS/LM
to determine the effect of oil overlay light mineral(LM) or paraffin oil (PO) in combination with paraffin oil 3D dishes (GPS).
Media microdroplet geometry (3D dishes) in combination with light mineral oil overlay
Media microdroplet geometry (3D dishes) in combination with Paraffin oil overlay
Other: SPL/PO versus SPL/LM
to determine the effect of oil overlay light mineral(LM) or paraffin oil (PO) in combination with paraffin oil 2D dishes (SPL).
Media microdroplet geometry (2D dishes) in combination with light mineral oil overlay
Media microdroplet geometry (2D dishes) in combination with paraffin oil overlay

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blastulation rate
Time Frame: 5-6 days after ICSI
Percentage of total blastocysts / Total cleaved embryos
5-6 days after ICSI
High quality blast rate
Time Frame: 5-6 days after ICSI
Morphological grading of trophectoderm and Inner cell mass using Gardner's criteria 1999, from grade A and B ( A is the highest quality). Total high grade embryos/ total blast embryos.
5-6 days after ICSI

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fertilization rate
Time Frame: 16-19 hours of ICSI
Percentage of fertilized oocyte (appearance of two pronuclei) / Number of injected oocytes
16-19 hours of ICSI
Cleavage rate
Time Frame: 72 hours of ICSI
Percentage of cleaved embryos/ total number of fertilized oocytes
72 hours of ICSI
High quality D3 embryos
Time Frame: 72 hours of ICSI
High quality D3 embryos according to Gardner's criteria / total cleaved embryos
72 hours of ICSI
Good quality trophectoderm/inner cell mass
Time Frame: 5-6 days after ICSI
better grade than 3BB of blast embryos according to Gardner's criteria 1999
5-6 days after ICSI

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

January 1, 2020

Study Completion (Actual)

January 10, 2020

Study Registration Dates

First Submitted

July 22, 2020

First Submitted That Met QC Criteria

July 22, 2020

First Posted (Actual)

July 24, 2020

Study Record Updates

Last Update Posted (Actual)

July 24, 2020

Last Update Submitted That Met QC Criteria

July 22, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MH0002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on GPS/LM

Subscribe